Therapeutic and prophylactic DNA vaccines for HIV-1. (Q38088037)

28 August 2017

title

Therapeutic and prophylactic DNA vaccines for HIV-1. (English)

1 reference

28 August 2017

author name string

Lorenzo Antonio Ramirez

series ordinal

1

1 reference

28 August 2017

Tatiana Arango

series ordinal

2

1 reference

28 August 2017

Jean Boyer

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

Expert Opinion on Biological Therapy

28 August 2017

published in

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

563-573

1 reference

Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Survival of persons with and without HIV infection in Denmark, 1995-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Progress in the development of an HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA vaccines: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA vaccines: an historical perspective and view to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA vaccines: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA vaccines for targeting bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

The future of human DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

An HIV vaccine--challenges and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Gene inoculation generates immune responses against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Protection against influenza virus challenge by topical application of influenza DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA mucosal HIV vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Nanochemistry-based immunotherapy for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Non-viral gene delivery with cationic liposome-DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

The molecular basis of electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Mechanism by which electroporation mediates DNA migration and entry into cells and targeted tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Electroporation for the efficient transfection of mammalian cells with DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Enhancement of DNA vaccine potency in rhesus macaques by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Issues for improving multiplasmid DNA vaccines for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Prospects of HIV Env modification as an approach to HIV vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

TLR9 as a key receptor for the recognition of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Accelerated immune senescence and HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

The influence of innate and pre-existing immunity on adenovirus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

HIV infection and the gastrointestinal immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

B lymphocytes as antigen-presenting cell-based genetic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

DNA vaccines--back in the saddle again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Micro pulsed radio-frequency electroporation chips.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Minimally invasive and surface electroporation delivery of DNA vaccines for the induction of robust humoral immune responses against HIV antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.758709

10.1517/14712598.2013.758709

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference